Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.
Also called NCT03015909
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 116 participants
- Sponsor
- Registry
-
NCT03015909
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03015909. Allocation not applicable; no masking; primary purpose treatment. Start 2016-08-11 (actual); primary completion 2017-12-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
- Condition
- Short Stature, Idiopathic
- Condition
- Infant, Small for Gestational Age
- Condition
- Growth Hormone Deficiency
- Condition
- Chronic Renal Failure
- Condition
- Turner Syndrome
- Intervention (Drug)
- Somatropin
- Lead sponsor
- LG Life Sciences
Record details
- Record id
cardio:ct-nct03015909- Content hash
97bcf8907ff7a1ff6e710f474bf585a151ef9a3168fc788ec56517ed8728b543